DCGO - NASDAQ
DocGo Inc.
$0.57
-4.1%DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.
At a Glance
Live SnapshotDocGo Inc. Management Team
Mr. Stephen Sugrue
Chief Compliance Officer
Compensation
$623,251
Mr. Lee Bienstock
Chief Executive Officer & Director
Compensation
$1,463,967
Dr. James Powell M.D.
Chief Executive Officer of Clinical Practice Group & Member of Medical Advisory Board
Mr. Eiwe Lingefors
Chief Information Officer
Mr. Andre Oberholzer CPA
Executive Vice President of Strategy
Compensation
$1,477,460
Mr. Ely D. Tendler J.D.
General Counsel, Secretary & Director
Compensation
$1,207,843
Mr. Norman Rosenberg
Treasurer & Chief Financial Officer
Compensation
$862,820
Ms. Rosemarie Milano
Vice President of Human Resources
Mr. Mike Cole
Vice President of Investor Relations
DocGo Inc. Insider Positioning
During the last 12 months, insiders have sold $72K worth of DCGO shares, with no buying activity reported.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
0
0.00
17.1K
17.53K
-18K
-$18K
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
0
0.00
35.7K
54.33K
-54K
-$54K
Top Buyers
No buying activity
Top Sellers
Bienstock Lee
Director, Officer: Chief Executive Officer
$28K
Rosenberg Norman
Officer: Cfo And Treasurer
$17K
Tendler Ely D
Director, Officer: General Counsel And Secretary
$15K
Sugrue Stephen
Officer: Chief Compliance Officer
$11K
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $72K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Insider Participation
4 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
SEC Filings
DCGO - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 22, 2026 | June 16, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 24, 2025 | June 17, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 25, 2024 | June 18, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | April 26, 2023 | June 20, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 29, 2022 | June 20, 2022 | 2022 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.